diffusion pharmaceuticals in a sentence

• It was through his association with the University of Virginia that Kalergis met Gainer, who was at that time a Professor of Chemical Engineering, leading to their collaboration in the founding of Diffusion Pharmaceuticals.
• The developer of oxygen diffusion-enhancing compounds, Diffusion Pharmaceuticals, tested its lead compound, trans sodium crocetinate ( TSC ), in a Phase II clinical trial in 59 patients newly diagnosed with glioblastoma multiforme.
• TSC, which is being developed by Diffusion Pharmaceuticals, has been shown to enhance the oxygenation of hypoxic tumor tissue and belongs to a subclass of oxygen diffusion-enhancing compounds known as bipolar trans carotenoid salts.
• TSC and other oxygen diffusion-enhancing compounds, including bipolar trans carotenoid salts ( the subclass to which TSC belongs ), have been investigated by Diffusion Pharmaceuticals for treatment of conditions associated with reduced oxygen availability in tissues ( hypoxia ).
• The drug has also been under investigation in a clinical trial sponsored by drug developer Diffusion Pharmaceuticals for potential use as a radiosensitizer, increasing the susceptibility of hypoxic cancer cells to radiation therapy, in patients with a form of brain cancer known as glioblastoma.
• "' Diffusion Pharmaceuticals LLC "'is a biotechnology and drug development company based in Charlottesville, Virginia, U . S . It was co-founded in 2001 by American life sciences entrepreneur David Kalergis and University of Virginia Chemical Engineering Professor John L . Gainer.
• It's difficult to see diffusion pharmaceuticals in a sentence .